SCHEMBL4254236

SCHEMBL4254236

CCCCCCCCCCCCc1ccccc1S(=O)(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.47
PPARA Q07869 3/20 0.44
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
ALOX5 P09917 1/20 0.43
PTGS2 P35354 1/20 0.43
BID P55957 3/20 0.41
MCL1 Q07820 3/20 0.41
BCL2L1 Q07817 2/20 0.41
BAK1 Q16611 2/20 0.41
KAT8 Q9H7Z6 2/20 0.41
PPARG P37231 2/20 0.41
EP300 Q09472 1/20 0.41
KAT2A Q92830 1/20 0.41
KAT2B Q92831 1/20 0.41
KAT5 Q92993 1/20 0.41
SAE1 Q9UBE0 1/20 0.41
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27828518 1.00 LIPG (0.47) LIPGPPARATHRATHRBNR1H2
SCHEMBL30336445 0.98 LIPG (0.46) LIPGPPARATHRATHRBNR1H2
Ammonia Solution, Strong SCHEMBL2109748 0.98 LIPG (0.46) LIPGPPARATHRATHRBNR1H2
SCHEMBL6363841 0.98 LIPG (0.46) LIPGPPARATHRATHRBNR1H2
SCHEMBL9452105 0.98 LIPG (0.46) LIPGPPARATHRATHRBNR1H2
SCHEMBL6064779 0.98 LIPG (0.46) LIPGPPARATHRATHRBNR1H2
SCHEMBL27828560 0.93 LIPG (0.39) LIPGPPARATHRATHRBNR1H2
SCHEMBL11588820 0.89 LIPG (0.49) LIPGPPARATHRATHRBNR1H2
SCHEMBL8982041 0.89 LIPG (0.49) LIPGPPARATHRATHRBNR1H2
SCHEMBL11592319 0.89 LIPG (0.49) LIPGPPARATHRATHRBNR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10066152-B2 Crosslinkable proppant particulates for use in subterranean formation operations HALLIBURTON ENERGY SERVICES, INC. (US) 2018-09-04 US claimed
US-20170198208-A1 Crosslinkable Proppant Particulates For Use In Subterranean Formation Operations HALLIBURTON ENERGY SERVICES, INC. (US) 2017-07-13 US claimed
WO-2016025002-A1 CROSSLINKABLE PROPPANT PARTICULATES FOR USE IN SUBTERRANEAN FORMATION OPERATIONS HALLIBURTON ENERGY SERVICES, INC. (US) 2016-02-18 WO claimed
US-20090149668-A1 Method for Producing Sodium Chloride-Free Ammonium Nitriles CLARIANT INTERNATIONAL, LTD. (CH) 2009-06-11 US claimed
EP-2001836-A1 IMPROVED METHOD FOR PRODUCING SODIUM CHLORIDE-FREE AMMONIUM NITRILES CLARIANT INTERNATIONAL LTD. (CH) 2008-12-17 EP claimed
WO-2007110163-A1 IMPROVED METHOD FOR PRODUCING SODIUM CHLORIDE-FREE AMMONIUM NITRILES CLARIANT INTERNATIONAL LTD (CH) 2007-10-04 WO claimed
US-20240401220-A1 SEALING SOLUTION KIT, TWO-STEP SEALING METHOD USING THE SAME AND ARTICLE HENKEL AG & CO KGAA (DE) 2024-12-05 US disclosed
EP-4453275-A1 SEALING SOLUTION KIT, TWO-STEP SEALING METHOD USING THE SAME AND ARTICLE Henkel AG & Co. KGaA (DE) 2024-10-30 EP disclosed
WO-2024144331-A1 XYLENE DIISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANURATE 한화솔루션 주식회사 2024-07-04 WO disclosed
WO-2023115366-A1 SEALING SOLUTION KIT, TWO-STEP SEALING METHOD USING THE SAME AND ARTICLE HENKEL AG & CO. KGAA (DE) 2023-06-29 WO disclosed
US-20230201646-A1 FIRE EXTINGUISHING COMPOSITIONS FOR LARGE FIRES FIREXO COTM LIMITED (GB) 2023-06-29 US disclosed
EP-4157468-A1 FIRE EXTINGUISHING COMPOSITIONS FOR LARGE FIRES Firexo COTM Limited (GB) 2023-04-05 EP disclosed
WO-2021240154-A1 FIRE EXTINGUISHING COMPOSITIONS FOR LARGE FIRES FIREXO GROUP LIMITED (GB) 2021-12-02 WO disclosed
EP-0023924-B1 TETRAALKYL PHOSPHONIUM SUBSTITUTED PHOSPHINE AND AMINE SUBSTITUTED TRANSITION METAL COMPLEXES EXXON RESEARCH AND ENGINEERING COMPANY (US) 1985-05-08 EP disclosed
US-4390729-A Process for carbonylation using tetraalkyl phosphonium substituted phosphine and amine transition metal complexes as catalyst EXXON RESEARCH AND ENGINEERING CO. (US) 1983-06-28 US disclosed
US-4302401-A Tetraalkyl phosphonium substituted phosphine and amine transition metal complexes EXXON RESEARCH & ENGINEERING CO. (US) 1981-11-24 US disclosed
US-4297803-A Composition useful for inhibiting adhesion and propagation of undesirable algae and/or shellfish on articles SAITO NORIO 1981-11-03 US disclosed
EP-0023924-A4 TETRAALKYL PHOSPHONIUM SUBSTITUTED PHOSPHINE AND AMINE SUBSTITUTED TRANSITION METAL COMPLEXES. EXXON RESEARCH ENGINEERING CO (US) 1981-07-16 EP disclosed
EP-0023924-A1 TETRAALKYL PHOSPHONIUM SUBSTITUTED PHOSPHINE AND AMINE SUBSTITUTED TRANSITION METAL COMPLEXES. EXXON RESEARCH ENGINEERING CO (US) 1981-02-18 EP disclosed
WO-1980001692-A1 TETRAALKYL PHOSPHONIUM SUBSTITUTED TRANSITION METAL COMPLEXES EXXON RESEARCH ENGINEERING CO (US) 1980-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149668-A1 Method for Producing Sodium Chloride-Free Ammonium Nitriles CBR3, CBR1, AKR1C3 LIPG 4744/4885PPARA 2437/4885THRA 1877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.